Variants of CARD8 in Leishmania guyanensis-cutaneous leishmaniasis and influence of the variants genotypes on circulating plasma cytokines IL-1β, TNFα and IL-8.
Cytokines
/ genetics
Genetic Predisposition to Disease
Genotype
Inflammasomes
/ genetics
Interleukin-8
Leishmania guyanensis
/ genetics
Leishmaniasis, Cutaneous
/ genetics
NLR Family, Pyrin Domain-Containing 3 Protein
/ genetics
Polymorphism, Single Nucleotide
Tumor Necrosis Factor-alpha
/ genetics
CARD Signaling Adaptor Proteins
/ genetics
Humans
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
10
10
2022
accepted:
24
05
2023
revised:
15
06
2023
medline:
19
6
2023
pubmed:
5
6
2023
entrez:
5
6
2023
Statut:
epublish
Résumé
Nucleotide-binding oligomerization domain, leucine-rich repeat-containing protein family (NLR) are intracellular pathogen recognition receptors mediating innate immunity, releasing proinflammatory cytokines IL-1β and IL-18, and promoting pyroptotic cell death, upon sensing pathogenic or endogenous danger signals. In animal models, NLRP3 inflammasome has a dual role, pathogenic or protective in Leishmania-infection, depending on the Leishmania species and mice strain. Caspase recruitment containing domain 8 (CARD8) is a negative regulator of NLRP3 inflammasome and also an inhibitor of transcription factor NFĸB, a major transcription factor of proinflammatory cytokines. We investigated whether single nucleotide variants in CARD8 may partially explain why only a proportion of individuals coming from the same area of endemicity of leishmaniasis develop cutaneous leishmaniasis caused by Leishmania guyanensis. We genotyped four single nucleotide variants of the CARD8 gene by direct nucleotide sequencing in 1741 individuals from an endemic area of leishmaniasis, constituting 850 patients with CL and 891 healthy controls. The frequencies of the genotypes of the variants rs2288877 T>C, rs73944113 C>T, and rs2043211 A>T are similar among the patients with CL and HC, while the variant rs2288876 A>G) reveals an excess of the genotype AA among the patients with CL (44%) compared to 37% in the HC group. Allele A of the variant rs2288876 A>G) is associated with susceptibility to CL (OR = 1.2 [95%CI 1.03-1.4]; P = 0.01). Haplotype analysis showed that individuals harboring the haplotype CCAA have 280% odds of developing CL caused by L. guyanensis (OR = 3.8 [95% CI 2.0-7.7]; p = 0.00004). The variants rs2288877 T>C and rs2288876 A>G correlate with the plasma level of IL-8. Spearman correlation showed a significant positive correlation between the rs2288876 A>G allele A and the level of IL-8 (ρ = 0.22; p = 0.0002). CARD8 may partially contribute to the development of CL caused by L. guyanensis.
Identifiants
pubmed: 37276232
doi: 10.1371/journal.pntd.0011416
pii: PNTD-D-22-01266
pmc: PMC10270566
doi:
Substances chimiques
Cytokines
0
Inflammasomes
0
Interleukin-8
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
Tumor Necrosis Factor-alpha
0
CARD8 protein, human
0
CARD Signaling Adaptor Proteins
0
IL1B protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0011416Informations de copyright
Copyright: © 2023 Sequera et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Rev Immunol. 2002 Nov;2(11):845-58
pubmed: 12415308
F1000Res. 2017 May 26;6:750
pubmed: 28649370
J Clin Invest. 2015 Mar 2;125(3):1329-38
pubmed: 25689249
Gastroenterology. 2006 Oct;131(4):1190-6
pubmed: 17030188
PLoS Pathog. 2017 Feb 13;13(2):e1006196
pubmed: 28192528
FASEB J. 2017 Nov;31(11):5087-5101
pubmed: 28765172
J Biol Chem. 2002 Apr 19;277(16):13952-8
pubmed: 11821383
Cell Physiol Biochem. 2017;41(1):173-180
pubmed: 28135700
An Bras Dermatol. 2011 Nov-Dec;86(6):1141-4
pubmed: 22281902
PLoS One. 2013 Oct 03;8(10):e75457
pubmed: 24098386
Brain Behav Immun. 2020 Aug;88:597-605
pubmed: 32335194
Front Immunol. 2022 Aug 25;13:974051
pubmed: 36091007
PLoS Pathog. 2020 Nov 2;16(11):e1008674
pubmed: 33137149
PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003868
pubmed: 26114647
J Leukoc Biol. 2018 Feb;103(2):233-257
pubmed: 28855232
Microbes Infect. 2004 Oct;6(12):1102-9
pubmed: 15380780
J Clin Microbiol. 2004 May;42(5):2294-7
pubmed: 15131217
J Hum Genet. 2011 Mar;56(3):217-23
pubmed: 21248762
J Invest Dermatol. 2015 Jan;135(1):94-101
pubmed: 25036052
Nat Commun. 2019 Nov 21;10(1):5273
pubmed: 31754185
Ann Rheum Dis. 2010 Apr;69(4):723-6
pubmed: 19443463
Cytokine. 2019 Nov;123:154788
pubmed: 31357078
PLoS Genet. 2014 Sep 25;10(9):e1004572
pubmed: 25254375
Cell Microbiol. 2015 Sep;17(9):1286-94
pubmed: 26249747
PLoS One. 2019 Aug 8;14(8):e0220572
pubmed: 31393896
J Immunol. 2007 Oct 1;179(7):4867-73
pubmed: 17878386
Immunol Rev. 2020 Sep;297(1):53-66
pubmed: 32564424
PLoS Negl Trop Dis. 2021 Sep 20;15(9):e0009795
pubmed: 34543271
J Infect Dis. 2022 Jan 5;225(1):163-171
pubmed: 34139757
J Clin Microbiol. 2003 Jul;41(7):3147-53
pubmed: 12843055
Eur J Immunol. 2016 Apr;46(4):897-911
pubmed: 26689285
Scand J Rheumatol. 2013;42(6):465-8
pubmed: 23547871
Science. 2008 Aug 15;321(5891):970-4
pubmed: 18703742
Curr Opin Immunol. 2018 Feb;50:32-38
pubmed: 29128729
Pathogens. 2021 Apr 20;10(4):
pubmed: 33924130
Am J Gastroenterol. 2009 May;104(5):1180-8
pubmed: 19319132
Methods Enzymol. 1980;65(1):347-53
pubmed: 6246357
Immunity. 2004 Mar;20(3):319-25
pubmed: 15030775
Arthritis Res Ther. 2014 Feb 12;16(1):R52
pubmed: 24517500
FEBS Lett. 2002 Jun 19;521(1-3):165-9
pubmed: 12067710
J Biol Chem. 2001 Nov 23;276(47):44069-77
pubmed: 11551959
Nucleic Acids Res. 1991 Mar 25;19(6):1346
pubmed: 2030954
PLoS Negl Trop Dis. 2012;6(5):e1533
pubmed: 22629474
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
Nat Med. 2013 Jul;19(7):909-15
pubmed: 23749230
Mediators Inflamm. 2015;2015:846782
pubmed: 25788762